News

Published on 1 May 2024 on Simply Wall St. via Yahoo Finance

AxoGen, Inc. (NASDAQ:AXGN) is largely controlled by institutional shareholders who own 58% of the...


Article preview image

Key Insights

Institutions' substantial holdings in AxoGen implies that they have significant influence over the company's share priceThe top 11 shareholders own 51% of the company Insiders have been selling lately

To get a sense of who is truly in control of AxoGen, Inc. (NASDAQ:AXGN), it is important to understand the ownership structure of the business. With 58% stake, institutions possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

NASDAQ.AXGN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
We Might See A Profit From Axogen, Inc. (NASDAQ:AXGN) Soon

Axogen, Inc. (NASDAQ:AXGN) is possibly approaching a major achievement in its business, so we wou...

Simply Wall St. · via Yahoo Finance 18 Feb 2025

AxoGen, Inc. (AXGN) Soars to 52-Week High, Time to Cash Out?

Have you been paying attention to shares of AxoGen (AXGN)? Shares have been on the move with the...

Zacks · via Yahoo Finance 13 Jan 2025

Those who invested in Axogen (NASDAQ:AXGN) a year ago are up 98%

The simplest way to invest in stocks is to buy exchange traded funds. But if you pick the right...

Simply Wall St. · via Yahoo Finance 6 Dec 2024

AxoGen Reports Strong Q3 2024 Revenue Growth

AxoGen ( (AXGN) ) just unveiled an update. Axogen, Inc., a leader in peripheral nerve repair solu...

TipRanks · via Yahoo Finance 8 Nov 2024

Axogen Inc (AXGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and...

Revenue: $48.6 million, an increase of approximately 18% compared to last year. Adjusted EBITDA:...

GuruFocus.com · via Yahoo Finance 7 Nov 2024

AxoGen's (AXGN) New Launch to Aid Peripheral Nerve Protection

AxoGen AXGN recently announced the full launch of its latest product, Avive+ Soft Tissue Matrix. ...

Zacks · via Yahoo Finance 18 Jun 2024

AxoGen, Inc. (NASDAQ:AXGN) is largely controlled by institutional shareholders who own 58% of the...

Key Insights Institutions' substantial holdings in AxoGen implies that they have significant infl...

Simply Wall St. via Yahoo Finance 1 May 2024

Analysts Expect Breakeven For AxoGen, Inc. (NASDAQ:AXGN) Before Long

AxoGen, Inc. (NASDAQ:AXGN) is possibly approaching a major achievement in its business, so we wou...

Simply Wall St. via Yahoo Finance 4 Apr 2024

Director Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN)

Director Gregory Freitag has sold 25,000 shares of Axogen Inc (NASDAQ:AXGN) on March 7, 2024, acc...

GuruFocus.com via Yahoo Finance 9 Mar 2024

US$13.80 - That's What Analysts Think AxoGen, Inc. (NASDAQ:AXGN) Is Worth After These Results

There's been a notable change in appetite for AxoGen, Inc. (NASDAQ:AXGN) shares in the week since...

Simply Wall St. via Yahoo Finance 8 Mar 2024